Targeted next-generation sequencing to diagnose disorders of HDL cholesterol

Journal of Lipid Research

Volumn 56, Issue 10, 2015, Pages 1993-2001

  Sadananda, Singh N ^a   Foo, Jia Nee ^b   Toh, Meng Tiak ^a   Cermakova, Lubomira ^c   Trigueros Motos, Laia ^a   Chan, Teddy ^d   Liany, Herty ^b   Collins, Jennifer A ^d   Gerami, Sima ^c   Singaraja, Roshni R ^a   Hayden, Michael R ^a,d,g   Francis, Gordon A ^c,d,e   Frohlich, Jiri ^c,f   Khor, Chiea Chuen ^b   Brunham, Liam R ^a,c,d,e,g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c ST PAUL S HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Atherosclerosis; ATP binding cassette transporter A1; Diagnostic tools; Genetics; Genomics; High density lipoprotein; Molecular diagnosis

Indexed keywords

DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ABC TRANSPORTER A1; ABCA1 PROTEIN, HUMAN;

ABCA1 GENE; ACCURACY; ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA FLANKING REGION; DNA SEQUENCE; EXON; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HYPOCHOLESTEROLEMIA; INTRON; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RISK FACTOR; UNTRANSLATED REGION; ALLELE; BLOOD; CARDIOVASCULAR DISEASES; GENETIC ASSOCIATION STUDY; GENETICS; HIGH THROUGHPUT SEQUENCING; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PROCEDURES;

ALLELES; ATP BINDING CASSETTE TRANSPORTER 1; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYPERCHOLESTEROLEMIA; INTRONS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84946553345     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P058891     Document Type: Article

References (31)

1. Yusuf, S., S. Hawken, S. Ounpuu, T. Dans, A. Avezum, F. Lanas, M. McQueen, A. Budaj, P. Pais, J. Varigos, et al. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 364: 937-952.
2. Boekholdt, S. M., B. J. Arsenault, G. K. Hovingh, S. Mora, T. R. Pedersen, J. C. Larosa, K. M. Welch, P. Amarenco, D. A. Demicco, A. M. Tonkin, et al. 2013. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation. 128: 1504-1512.
3. Barter, P., A. M. Gotto, J. C. LaRosa, J. Maroni, M. Szarek, S. M. Grundy, J. J. Kastelein, V. Bittner, and J. C. Fruchart ; Treating to New Targets Investigators. 2007. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med. 357: 1301-1310.
4. Goode, E. L., S. S. Cherny, J. C. Christian, G. P. Jarvik, and M. de Andrade. 2007. Heritability of longitudinal measures of body mass index and lipid and lipoprotein levels in aging twins. Twin Res. Hum. Genet. 10: 703-711.
5. Cohen, J. C., R. S. Kiss, A. Pertsemlidis, Y. L. Marcel, R. McPherson, and H. H. Hobbs. 2004. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 305: 869-872.
6. Tietjen, I., G. K. Hovingh, R. Singaraja, C. Radomski, J. McEwen, E. Chan, M. Mattice, A. Legendre, J. J. Kastelein, and M. R. Hayden. 2012. Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT. Biochim. Biophys. Acta. 1821: 416-424.
7. Frikke-Schmidt, R., B. G. Nordestgaard, M. C. Stene, A. A. Sethi, A. T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen. 2008. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA. 299: 2524-2532.
8. Kiss, R. S., N. Kavaslar, K. Okuhira, M. W. Freeman, S. Walter, R. W. Milne, R. McPherson, and Y. L. Marcel. 2007. Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects. Arterioscler. Thromb. Vasc. Biol. 27: 1139-1145.
9. Berge, K. E., and T. P. Leren. 2010. Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterol. Clin. Chim. Acta. 411: 2019-2023.
10. Candini, C., A. W. Schimmel, J. Peter, A. E. Bochem, A. G. Holleboom, M. Vergeer, R. P. Dullaart, G. M. Dallinga-Thie, G. K. Hovingh, K. L. Khoo, et al. 2010. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. Atherosclerosis. 213: 492-498.
11. Alrasadi, K., I. L. Ruel, M. Marcil, and J. Genest. 2006. Functional mutations of the ABCA1 gene in subjects of French-Canadian descent with HDL deficiency. Atherosclerosis. 188: 281-291.
12. Motazacker, M. M., J. Peter, M. Treskes, C. C. Shoulders, J. A. Kuivenhoven, and G. K. Hovingh. 2013. Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levels. Arte-rioscler. Thromb. Vasc. Biol. 33: 1521-1528.
13. Rehm, H. L. 2013. Disease-targeted sequencing: a cornerstone in the clinic. Nat. Rev. Genet. 14: 295-300.
14. Heiss, G., N. J. Johnson, S. Reiland, C. E. Davis, and H. A. Tyroler. 1980. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Summary. Circulation. 62: IV116-IV136.
15. Brunham, L. R., M. H. Kang, C. Van Karnebeek, S. N. Sadananda, J. A. Collins, L. H. Zhang, B. Sayson, F. Miao, S. Stockler, J. Frohlich, et al. 2015. Clinical, biochemical, and molecular characterization of novel mutations in ABCA1 in families with Tangier disease. JIMD Rep. 18: 51-62.
16. Stenson, P. D., M. Mort, E. V. Ball, K. Howells, A. D. Phillips, N. S. Thomas, and D. N. Cooper. 2009. The Human Gene Mutation Database: 2008 update. Genome Med. 1: 13.
17. Juren, A. J., G. Sarwal, A. Al-Sarraf, M. Vrablik, D. Chan, K. H. Humphries, and J. J. Frohlich. 2013. Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipo-protein cholesterol. J. Clin. Lipidol. 7: 194-198.
18. Richards, C. S., S. Bale, D. B. Bellissimo, S. Das, W. W. Grody, M. R. Hegde, E. Lyon, and B. E. Ward ; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. 2008. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet. Med. 10: 294-300.
19. Probst, M. C., H. Thumann, C. Aslanidis, T. Langmann, C. Buechler, W. Patsch, F. E. Baralle, G. M. Dallinga-Thie, J. Geisel, C. Keller, et al. 2004. Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis. 175: 269-279.
20. Khetarpal, S. A., A. C. Edmondson, A. Raghavan, H. Neeli, W. Jin, K. O. Badellino, S. Demissie, A. K. Manning, S. L. DerOhannessian, M. L. Wolfe, et al. 2011. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol. PLoS Genet. 7: e1002393.
21. Brunham, L. R., I. Tietjen, A. E. Bochem, R. R. Singaraja, P. L. Franchini, C. Radomski, M. Mattice, A. Legendre, G. K. Hovingh, J. J. Kastelein, et al. 2011. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans. Clin. Genet. 79: 575-581.
22. Singaraja, R. R., H. Visscher, E. R. James, A. Chroni, J. M. Coutinho, L. R. Brunham, M. H. Kang, V. I. Zannis, G. Chimini, and M. R. Hayden. 2006. Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ. Res. 99: 389-397.
23. Haase, C. L., A. Tybjaerg-Hansen, A. A. Qayyum, J. Schou, B. G. Nordestgaard, and R. Frikke-Schmidt. 2012. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54, 500 individuals. J. Clin. Endocrinol. Metab. 97: E248-E256.
24. Tängemo, C., D. Weber, S. Theiss, E. Mengel, and H. Runz. 2011. Niemann-Pick Type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage. J. Lipid Res. 52: 813-825.
25. Garver, W. S., D. Jelinek, F. J. Meaney, J. Flynn, K. M. Pettit, G. Shepherd, R. A. Heidenreich, C. M. Vockley, G. Castro, and G. A. Francis. 2010. The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes. J. Lipid Res. 51: 406-415.
26. Choi, H. Y., B. Karten, T. Chan, J. E. Vance, W. L. Greer, R. A. Heidenreich, W. S. Garver, and G. A. Francis. 2003. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J. Biol. Chem. 278: 32569-32577.
27. Johansen, C. T., J. B. Dube, M. N. Loyzer, A. Macdonald, D. E. Carter, A. D. McIntyre, H. Cao, J. Wang, J. F. Robinson, and R. A. Hegele. 2014. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias. J. Lipid Res. 55: 765-772.
28. Huijgen, R., I. Kindt, S. B. Verhoeven, E. J. Sijbrands, M. N. Vissers, J. J. Kastelein, and B. A. Hutten. 2010. Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. PLoS One. 5: e9220.
29. Umans-Eckenhausen, M. A., J. C. Defesche, M. J. van Dam, and J. J. Kastelein. 2003. Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. Arch. Intern. Med. 163: 65-68.
30. Stoekenbroek, R. M., M. A. van den Bergh Weerman, G. K. Hovingh, B. J. Potter van Loon, C. E. Siegert, and A. G. Holleboom. 2013. Familial LCAT deficiency: from renal replacement to enzyme replacement. Neth. J. Med. 71: 29-31.
31. Alphacore Pharma, LLC. 2012. Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects with Coronary Artery Disease. In Clinicaltrials.gov [Internet]. National Library of Medicine (US), Bethesda, MD. Accessed June 5, 2015, at https://clinicaltrials.gov/show/NCT01554800.